Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review

Date: June 23, 2015
Pages: 34
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review
Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Divi’s Laboratories Limited (Divi’s) is a pharmaceutical company. It focuses on the manufacturing of a broad range Active Pharmaceutical Ingredients (APIs) and intermediates. The company reports its business in a single segment, namely, manufacturing and sale of APIs and intermediates. The product portfolio of the company includes generic APIs, nutraceuticals, custom synthesis of APIs, intermediates and specialty ingredients. The company operates across the world including several countries in Europe and in America. The company operates two subsidiaries namely, Divi’s Laboratories USA Inc., and Divi’s Laboratories Europe AG. It operates manufacturing and research and development units in Hyderabad and Visakhapatnam, India. Divi’s is headquartered in Hyderabad, India.

Divi's Laboratories Limited Key Recent Developments

Jan 31, 2015: Proposal for Setting up a third Manufacturing Site
Jan 31, 2015: Divi’s Labs earns a PAT of Rs.221 crores in Q3/FY15
May 20, 2013: Divi's Labs Reports Revenue Of INR21.4 Billion In Fiscal 2013
Feb 02, 2013: Divi's Labs Reports Revenue Of INR5.3 Billion In Q3 Fiscal 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Divi's Laboratories Limited - Key Facts
Divi's Laboratories Limited - Key Employees
Divi's Laboratories Limited - Key Employee Biographies
Divi's Laboratories Limited - Major Products and Services
Divi's Laboratories Limited - History
Divi's Laboratories Limited - Company Statement
Divi's Laboratories Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Divi's Laboratories Limited - Key Manufacturing Facilities


Divi's Laboratories Limited - Business Description
Divi's Laboratories Limited - Corporate Strategy
Divi's Laboratories Limited - SWOT Analysis
SWOT Analysis - Overview
Divi's Laboratories Limited - Strengths
Strength - Production Capabilities
Strength - Sturdy R&D Activities
Strength - Improved Financial Performance
Divi's Laboratories Limited - Weaknesses
Weakness - Limited Customer Base
Weakness - Cost Control
Divi's Laboratories Limited - Opportunities
Opportunity - Global Pharmaceutical Outsourcing Market
Opportunity - Surging Demand for Generics
Opportunity - Strategic Expansion Initiatives
Divi's Laboratories Limited - Threats
Threat - Competitive Pressures
Threat - Industry Consolidation
Threat - Stringent Government Regulations
Divi's Laboratories Limited - Key Competitors


Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts


Jan 31, 2015: Proposal for Setting up a third Manufacturing Site
Jan 31, 2015: Divi’s Labs earns a PAT of Rs.221 crores in Q3/FY15
Nov 01, 2014: Divi’s Labs earns a PAT of Rs.230 crores in Q2 of FY15


Ratio Definitions
About GlobalData
Contact Us


Divi's Laboratories Limited, Key Facts
Divi's Laboratories Limited, Key Employees
Divi's Laboratories Limited, Key Employee Biographies
Divi's Laboratories Limited, Major Products and Services
Divi's Laboratories Limited, History
Divi's Laboratories Limited, Other Locations
Divi's Laboratories Limited, Subsidiaries
Divi's Laboratories Limited, Key Manufacturing Facilities
Divi's Laboratories Limited, Key Competitors
Divi's Laboratories Limited, Ratios based on current share price
Divi's Laboratories Limited, Annual Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios


Divi's Laboratories Limited, Performance Chart (2011 - 2015)
Divi's Laboratories Limited, Ratio Charts
Skip to top

Ask Your Question

Divi's Laboratories Limited (DIVISLAB) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: